The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study

BACKGROUND: Randomized clinical trials of spironolactone showed significant mortality reduction in patients with heart failure with reduced ejection fraction. However, its role in acute heart failure syndrome (AHFS) is largely unknown. AIM: To investigate the prescription characteristics, efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Soo Jin, Youn, Jong-Chan, Lee, Hye Sun, Jeon, Soyoung, Lee, Hae-Young, Cho, Hyun-Jai, Choi, Jin-Oh, Jeon, Eun-Seok, Lee, Sang Eun, Kim, Min-Seok, Kim, Jae-Joong, Hwang, Kyung-Kuk, Cho, Myeong-Chan, Chae, Shung Chull, Kang, Seok-Min, Choi, Dong-Ju, Yoo, Byung-Su, Kim, Kye Hun, Oh, Byung-Hee, Baek, Sang Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902170/
https://www.ncbi.nlm.nih.gov/pubmed/35274010
http://dx.doi.org/10.3389/fcvm.2022.791446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902170/
https://www.ncbi.nlm.nih.gov/pubmed/35274010
http://dx.doi.org/10.3389/fcvm.2022.791446

Ejemplares similares